Early appetite changes are common, while fat loss often follows as doses increase
R Hurrell, I Egli
Nee, GLP-1 medicatie werkt niet bij iedereen hetzelfde
As two negative regulators of p53, MDM2 and MDMX facilitate ferroptosis with or without p53, most likely by altering the lipid profile of cells (Venkatesh et al., 2020), which is confirmed by evidence that with the treatment of MDM2 inhibitor nutlin-3, p53 expression increases and leads to the suppression of X c system inhibitor-induced ferroptosis in HT-1080 cells (Tarangelo et al., 2018)
This effect is particularly enhanced when used in conjunction with weight loss programs, such as Intermittent Fasting (IF) or regular exercise, yielding even better results
Those are GLP-1 receptor agonists, not growth hormone peptides